NICE - National Institute for Health and Care Excellence

Try a search

• Is pembrolizumab recommended by NICE for non-small-cell lung cancer?
• Which NICE technology appraisals published since September 2026 were not recommended?
• Which drugs are currently funded through the Cancer Drugs Fund?
• Which NICE appraisals of bladder cancer drugs are in development and when are they expected?

Tools (2)

1. searchNiceTechnologyAppraisalsSearch NICE (England) technology appraisal (TA) and highly specialised technology (HST) decisions by technology/INN, indication, recommendation outcome, guidance id and date. Returns one row per appraised indication with NICE's recommendation (recommended, optimised = recommended for a narrower population, notRecommended, onlyInResearch, terminated = no company submission), Cancer Drugs Fund flags and the recommendation wording. Rows without a recommendation are HST guidance or TAs published after NICE's last monthly data-file update: open the url. Use searchNiceGuidance for appraisals in development and other NICE guidance.Free
2. searchNiceGuidanceLive search of all NICE (England) guidance by keyword, programme and status: technology appraisals (including those in development with their expected publication date, terminated or awaiting development), highly specialised technologies, NICE guidelines, interventional procedures, diagnostics and HealthTech guidance. Returns guidance ids, status and dates, not recommendation outcomes: use searchNiceTechnologyAppraisals for the TA recommendation per indication.Free